Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LENZ Therapeutics (LENZ) Change in Accured Expenses (2022 - 2023)

Historic Change in Accured Expenses for Therapeutics (LENZ) over the last 2 years, with Q4 2023 value amounting to $1.6 million.

  • Therapeutics' Change in Accured Expenses rose 25673.29% to $1.6 million in Q4 2023 from the same period last year, while for Dec 2023 it was $7.8 million, marking a year-over-year increase of 60117.12%. This contributed to the annual value of -$7.5 million for FY2024, which is 19584.99% down from last year.
  • Therapeutics' Change in Accured Expenses amounted to $1.6 million in Q4 2023, which was up 25673.29% from $3.3 million recorded in Q3 2023.
  • In the past 5 years, Therapeutics' Change in Accured Expenses registered a high of $3.3 million during Q3 2023, and its lowest value of -$1.7 million during Q1 2022.